New findings help explain brain inflammation in Alzheimer's patients
新發現有助於解釋阿茲海默症患者的腦部發炎現象
更新於: 2026年7月21日 上午12:45
Recent research has triggered a paradigm shift in how we understand Alzheimer’s disease.
近期的研究引發了對阿茲海默症理解的範式轉移。
For years, scientists viewed brain inflammation as a minor side effect of the condition, but new findings suggest it is a primary driver of the disease, acting as a 'third core pathology.'
多年來，科學家將大腦發炎視為該疾病的輕微副作用，但新的發現表明，它是疾病的主要驅動因素，充當了「第三核心病理」。
The brain's resident immune cells, known as microglia, are central to this process.
大腦內部的免疫細胞（即微膠質細胞）在此過程中起著關鍵作用。
This persistent activation leads to the release of toxic proteins that damage neurons and disrupt cognitive function.
這種持續的激活導致有毒蛋白質釋放，進而損傷神經元並破壞認知功能。
Key mechanisms, such as the formation of myddosomes and the chemical modification of the STING protein, keep the immune system stuck in this damaging state.
諸如肌球體（myddosomes）的形成和STING蛋白質的化學修飾等關鍵機制，使免疫系統陷入這種破壞性的狀態。
Scientists have also identified how amyloid proteins interact with Hv1 channels to amplify this inflammatory response.
科學家還確認了澱粉樣蛋白質如何與Hv1離子通道相互作用，從而增強這種發炎反應。
Importantly, this research highlights that inflammation is a 'double-edged sword.'
重要的是，這項研究強調發炎是一把「雙刃劍」。
Because we need an immune response for brain health, the goal for future therapies is not to eliminate inflammation entirely, but to fine-tune it.
由於我們的大腦健康需要免疫反應，未來治療的目標不是徹底消除發炎，而是對其進行微調。
By targeting pathways like TNF-α, researchers hope to develop treatments that can slow cognitive decline, offering new hope for intervention.
通過針對如TNF-α等途徑，研究人員希望開發出能夠減緩認知能力衰退的療法，為干預治療提供了新的希望。
